Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)

Funding Agency:
National Institutes of Health
The purpose of this Funding Opportunity Announcement (FOA) is to invite new and renewal applications for the Rare Diseases Clinical Research Consortia (RDCRC) that comprise the Rare Diseases Clinical Research Network (RDCRN).  The RDCRCs are intended to advance the diagnosis, management, and treatment of rare diseases with a focus on clinical trial readiness.  Each RDCRC will promote highly collaborative, multi-site, patient-centric, translational and clinical research with the intent of addressing unmet clinical trial readiness needs.
 
Companion FOA: Data Management and Coordinating Center (DMCC) (RFA-TR-18-021)
 
Deadlines:
  • Letter of Intent Due Date(s): September 9, 2018
  • Application Due Date(s): October 9, 2018

RFA-TR-18-020 Expiration Date December 17, 2014
 

Agency Website

Eligibility Requirements

The minimum cumulative effort of the PD/PI(s) should be at least 2.1 person months per year.  

The RDCRC PD/PI(s) cannot serve as the Program Director/Principal Investigator of a project in another active RDCRN award.

      Amount

      $5,000,000

      Amount Description

      Applicants may request up to $1 million in direct costs/year. For the Career Enhancement core, there is a cap of $100,000 direct costs/year for the duration of the awards.

      Applicants may request up to 5 years of support.   

          Funding Type

          Grant

          Eligibility

          Faculty
          Institutional

          Category

          Medical
          Medical - Basic Science
          Medical - Clinical Science
          Medical - Translational

          External Deadline

          October 9, 2018